Cardiovascular changes in children with pneumonia

Fadime Ilten1, Filiz Senocak, Pelin Zorlu

  • 1Dr. Sami Ulus Children's Hospital Ankara, Turkey.

Insights

Childhood pneumonia can affect the heart, increasing the risk of myocarditis. Noninvasive tests like ECG and echocardiography are crucial for detecting these cardiovascular changes in infants with pneumonia.

Area of Science:

  • Pediatrics
  • Cardiology
  • Infectious Diseases

Background:

  • Pneumonia is a leading cause of childhood mortality, particularly in infants.
  • Cardiovascular system integrity is vital and can be compromised during severe respiratory infections.

Purpose of the Study:

  • To evaluate cardiovascular changes in infants with pneumonia using noninvasive methods.
  • To assess the correlation between pneumonia severity and cardiac function indicators.

Main Methods:

  • Prospective study of 50 infants (2-24 months) hospitalized with pneumonia.
  • Utilized complete blood counts, blood gases, ECG, echocardiography, and cardiac enzyme measurements (CK-MB).
  • Evaluations performed at admission and post-recovery.

Main Results:

  • Elevated right ventricular systolic pressure (RVSP) in 70% of patients, correlating with pneumonia severity.
  • Normal left ventricular function, but elevated CK-MB in 68% of infants.
  • Congestive heart failure occurred in 7 cases, with 3 deaths; elevated CK-MB was noted in fatal cases and most heart failure cases.

Conclusions:

  • Pneumonia in infants may be associated with a higher incidence of myocarditis than previously recognized.
  • Early detection of myocarditis via noninvasive techniques (ECG, echocardiography, cardiac enzymes) is critical due to its potential fatality.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: